Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris?
McFadden
E R
ER
Division of Pulmonary and Critical Care Medicine, University Hospitals of Cleveland, OH 44106.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D005544:Forecasting; D006801:Humans; D012307:Risk Factors
D000318:Adrenergic beta-Agonists; D000336:Aerosols